G. Daum et al., THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY CONTRIBUTES TO VANADATE TOXICITY IN VASCULAR SMOOTH-MUSCLE CELLS, Molecular and cellular biochemistry, 183(1-2), 1998, pp. 97-103
Vanadate has been considered in the treatment of diabetes because of i
ts insulin-like effects. However, it has severe toxic effects in both
animal and man. In cultured cells, vanadate can either cause death or
be growth stimulatory, depending on the cell type and growth condition
s. Here, we report that in baboon aortic smooth muscle cells (SMCs), v
anadate induced p42/p44 mitogen-activated protein kinase (MAPK) activi
ty. This effect was abolished in the presence of the specific MAPK kin
ase (MAPKK) inhibitor PD098059. Although activation of p42/p44(MAPK)/M
APKK is generally thought to be necessary for proliferation, in SMCs,
vanadate did not promote DNA synthesis and inhibited thymidine incorpo
ration stimulated by platelet-derived growth factor (PDGF)-BB in a dos
e dependent fashion (IC50: 30 mu M). Prolonged exposure to vanadate ex
erted cytotoxic effects. Cells retracted, rounded up and detached from
the substratum. These vanadate-induced morphological changes were blo
cked in the presence of PD098059. The addition of PDGF-BB further acti
vated p42/ p44(MAPK)/MAPKK in the presence of vanadate and substantial
ly increased vanadate toxicity. We conclude from these observations th
at activation of the p42/p44(MAPK)/MAPKK signalling module contributes
to the cytotoxic effects induced by vanadate.